Prevalence and correlates of vertebral fractures in adults with cystic fibrosis.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 15336615)

Published in Bone on September 01, 2004

Authors

M Rossini1, A Del Marco, F Dal Santo, D Gatti, C Braggion, G James, S Adami

Author Affiliations

1: Rheumatology Unit, Osteoporosis Center, University of Verona, 37122, Verona, Italy. maurizio.rossini@libero.it

Articles citing this

Compromised bone microarchitecture and estimated bone strength in young adults with cystic fibrosis. J Clin Endocrinol Metab (2014) 2.08

The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2008) 1.86

Vitamin D and bone health in adults with cystic fibrosis. Clin Endocrinol (Oxf) (2008) 1.20

Cystic fibrosis-related bone disease: insights into a growing problem. Curr Opin Endocrinol Diabetes Obes (2013) 0.86

Dysplastic spondylolysis is caused by mutations in the diastrophic dysplasia sulfate transporter gene. Proc Natl Acad Sci U S A (2015) 0.86

Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation. Pediatr Res (2009) 0.83

Trends in bone mineral density in young adults with cystic fibrosis over a 15 year period. J Cyst Fibros (2015) 0.82

Deficits in bone mineral content in children and adolescents with cystic fibrosis are related to height deficits. J Clin Densitom (2008) 0.81

Longitudinal analysis of vertebral fracture and BMD in a Canadian cohort of adult cystic fibrosis patients. BMC Musculoskelet Disord (2008) 0.81

Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis. Thorax (2005) 0.80

Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies. Osteoporos Int (2015) 0.79

Reduced bone volumetric density and weak correlation between infection and bone markers in cystic fibrosis adult patients. Osteoporos Int (2016) 0.77

Bone mineral and body composition alterations in paediatric cystic fibrosis patients. Pediatr Radiol (2009) 0.77

Endocrine Disorders in Cystic Fibrosis. Pediatr Clin North Am (2016) 0.75

Articles by these authors

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med (2001) 9.57

Poverty and public health--new outlooks. I. Poverty as an obstacle to health progress in our cities. Am J Public Health Nations Health (1965) 4.53

Biofilms, the customized microniche. J Bacteriol (1994) 4.33

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab (2005) 3.67

Alendronate for the treatment of osteoporosis in men. N Engl J Med (2000) 3.11

Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int (2006) 2.79

Survival analysis in percutaneous endoscopic gastrostomy feeding: a worse outcome in patients with dementia. Am J Gastroenterol (2000) 2.60

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res (2003) 2.50

A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol (2000) 2.47

Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups. JAMA (1997) 2.46

The anti-coronary club. A dietary approach to the prevention of coronary heart disease--a seven-year report. Am J Public Health Nations Health (1966) 2.42

FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell (1992) 2.28

The time course of a hypercalcaemic crisis in acute primary hyperparathyroidism. Lancet (1984) 2.21

Hospital epidemiology. Its development and potential. JAMA (1965) 2.05

Site-specific effects of strength training on bone structure and geometry of ultradistal radius in postmenopausal women. J Bone Miner Res (1999) 2.05

Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR-based assays. J Clin Microbiol (2000) 1.94

The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85

Quantitative heel ultrasound in a population-based study in Italy and its relationship with fracture history: the ESOPO study. Osteoporos Int (2005) 1.80

Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res (2000) 1.80

Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data. Osteoporos Int (2008) 1.76

High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care (2001) 1.74

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. Ann Rheum Dis (2005) 1.66

Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group. Aging (Milano) (2000) 1.59

Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review. J Hosp Infect (2006) 1.57

Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey. Osteoporos Int (2006) 1.54

Phylogenetic analysis of Ureaplasma urealyticum--support for the establishment of a new species, Ureaplasma parvum. Int J Syst Bacteriol (1999) 1.49

Bone loss in response to long-term glucocorticoid therapy. Bone Miner (1990) 1.44

Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab (1999) 1.43

Tolerability of risedronate in postmenopausal women intolerant of alendronate. Aging (Milano) (2001) 1.40

Biofilm maturity studies indicate sharp debridement opens a time- dependent therapeutic window. J Wound Care (2010) 1.39

Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J Antimicrob Chemother (2008) 1.37

Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int (2003) 1.36

Travel-associated Burkholderia pseudomallei infection (Melioidosis) in a patient with cystic fibrosis: a case report. Clin Infect Dis (2000) 1.36

Cytochrome oxidase assembly in yeast requires the product of COX11, a homolog of the P. denitrificans protein encoded by ORF3. EMBO J (1990) 1.28

The future role of schools of public health. I. Am J Public Health Nations Health (1970) 1.27

Species-specific PCR for identification of common contaminant mollicutes in cell culture. Appl Environ Microbiol (2001) 1.27

Family planning and the Department of Health of the city of New York. Bull N Y Acad Med (1966) 1.26

Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int (2012) 1.25

Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis. J Bone Miner Res (2002) 1.22

Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int (1997) 1.22

Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int (1988) 1.18

Functions of optic nerve glia: axoglial signalling in physiology and pathology. Eye (Lond) (2004) 1.17

Characterization of the microflora of the human axilla. Int J Cosmet Sci (2003) 1.17

Radioimmunoassay of 1,25-dihydroxy vitamin D2: studies on the metabolism of vitamin D2 in man. Clin Endocrinol (Oxf) (1983) 1.13

Differential protein expression in the prefrontal white matter of human alcoholics: a proteomics study. Mol Psychiatry (2006) 1.13

Hypomagnesaemia: studies of parathyroid hormone secretion and function. Clin Endocrinol (Oxf) (1984) 1.08

The role and contribution of epidemiology in planning, operation, and evaluation of Regional Medical Programs (heart, cancer, and stroke). I. Epidemiology and Regional Medical Programs. Am J Public Health Nations Health (1968) 1.08

Identification by 16S rRNA gene analyses of a potential novel mycobacterial species as an etiological agent of canine leproid granuloma syndrome. J Clin Microbiol (2000) 1.08

Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib. Ann Rheum Dis (2004) 1.06

Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). Osteoporos Int (2007) 1.03

[Incidence and socioeconomic burden of hip fractures in Italy]. Reumatismo (2005) 1.02

Sources and impact of artifacts on clinical three-dimensional ultrasound imaging. Ultrasound Obstet Gynecol (2000) 1.02

Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton. J Urol (1985) 1.02

Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol. J Bone Miner Res (2000) 1.01

Effects of strontium ranelate on spinal osteoarthritis progression. Ann Rheum Dis (2007) 1.01

Intravenous neridronate in adults with osteogenesis imperfecta. J Bone Miner Res (2003) 1.01

Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int (2013) 1.00

Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function. Kidney Int (1990) 1.00

Luminescence control in the marine bacterium Vibrio fischeri: An analysis of the dynamics of lux regulation. J Mol Biol (2000) 1.00

Relation between adiponectin and bone mineral density in elderly post-menopausal women: role of body composition, leptin, insulin resistance, and dehydroepiandrosterone sulfate. J Endocrinol Invest (2008) 1.00

[Guidelines on prevention and treatment of vitamin D deficiency. Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS)]. Reumatismo (2011) 0.97

Using an efficient biofilm detaching agent: an essential step for the improvement of endoscope reprocessing protocols. J Hosp Infect (2006) 0.96

The function of health facilities in the total medical care complex. Public Health Rep (1966) 0.96

Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy. Calcif Tissue Int (2001) 0.96

Molecular genotyping of human Ureaplasma species based on multiple-banded antigen (MBA) gene sequences. Int J Syst Evol Microbiol (2000) 0.95

Age-related cortical bone loss at the metacarpal. Calcif Tissue Int (1997) 0.95

Relationship among VDR (BsmI and FokI), COLIA1, and CTR polymorphisms with bone mass, bone turnover markers, and sex hormones in men. Calcif Tissue Int (2002) 0.95

Health education and health promotion: a look at the jungle of supportive fields, philosophies and theoretical foundations. Health Educ (1990) 0.95

Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis. J Bone Miner Res (1994) 0.94

Nonlinear analysis of the dynamics of DNA breathing. J Biol Phys (2009) 0.94

Sequential changes in plasma luteinizing hormone and plasma prorenin during the menstrual cycle. J Clin Endocrinol Metab (1987) 0.94

Bisphosphonate therapy of reflex sympathetic dystrophy syndrome. Ann Rheum Dis (1997) 0.94

Association of CTR and COLIA1 alleles with BMD values in peri- and postmenopausal women. Calcif Tissue Int (2000) 0.93

Feline leprosy: two different clinical syndromes. J Feline Med Surg (2002) 0.93

Molecular control of myogenesis: antagonism between growth and differentiation. Mol Cell Biochem (1991) 0.93

Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism. J Bone Miner Res (2001) 0.93

Testing wound dressings using an in vitro wound model. J Wound Care (2010) 0.93

Redox-linked proton translocation in the b-c1 complex from beef-heart mitochondria reconstituted into phospholipid vesicles. Studies with chemical modifiers of amino acid residues. Eur J Biochem (1983) 0.92

Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate. Calcif Tissue Int (1986) 0.92

Molecular epidemiology of meticillin-resistant Staphylococcus aureus in Italian cystic fibrosis patients: a national overview. J Cyst Fibros (2011) 0.92

New horizons for cutaneous microbiology: the role of biofilms in dermatological disease. Br J Dermatol (2011) 0.92

Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). QJM (2006) 0.92

The effects of menopause and estrogen replacement therapy on the renal handling of calcium. Osteoporos Int (1992) 0.92

Osteochondrodysplasia in Scottish Fold cats. Aust Vet J (1999) 0.91

The emergency room: entry to the health-care system. Hosp Top (1969) 0.91

Familial benign hypercalcaemia. Study of a large family. Q J Med (1983) 0.91

A nutritional epidemiologic investigation of 642 New York City children. Am J Clin Nutr (1968) 0.91

Percutaneous endoscopic gastrostomy: a prospective audit of the impact of guidelines in two district general hospitals in the United Kingdom. Am J Gastroenterol (2002) 0.91

The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate. Bone Miner (1991) 0.90

Cytochemical bioassay of parathyroid hormone in maternal and cord blood. Arch Dis Child (1985) 0.88

Height, bone mineral density and bone markers in congenital adrenal hyperplasia. Horm Res (2000) 0.88

New perspectives on the definition and the management of severe osteoporosis: the patient with two or more fragility fractures. J Endocrinol Invest (2009) 0.88

Computed radiographic absorptiometry and morphometry in the assessment of postmenopausal bone loss. Osteoporos Int (1996) 0.88

Quantitative ultrasound calcaneous measurements: normative data for the Italian population. the ESOPO study. J Clin Densitom (2007) 0.87

Structure-function correlations of the reaction of reduced nicotinamide analogues with p-hydroxybenzoate hydroxylase substituted with a series of 8-substituted flavins. Biochemistry (1999) 0.87